Idiopathic pulmonary fibrosis cluster analysis highlights diagnostic delay and cardiovascular comorbidity association with outcome.


Journal

ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 02 12 2020
accepted: 07 03 2021
entrez: 13 5 2021
pubmed: 14 5 2021
medline: 14 5 2021
Statut: epublish

Résumé

Idiopathic pulmonary fibrosis (IPF) prognosis is heterogeneous despite antifibrotic treatment. Cluster analysis has proven to be a useful tool in identifying interstitial lung disease phenotypes, which has yet to be performed in IPF. The aim of this study is to identify phenotypes of IPF with different prognoses and requirements. Observational retrospective study including 136 IPF patients receiving antifibrotic treatment between 2012 and 2018. Six patients were excluded due to follow-up in other centres. Cluster analysis of 30 variables was performed using approximate singular value-based tensor decomposition method and comparative statistical analysis. The cluster analysis identified three different groups of patients according to disease behaviour and clinical features, including mortality, lung transplant and progression-free survival time after 3-year follow-up. Cluster 1 (n=60) was significantly associated (p=0.02) with higher mortality. Diagnostic delay was the most relevant characteristic of this cluster, as 48% of patients had ≥2 years from first respiratory symptoms to antifibrotic treatment initiation. Cluster 2 (n=22) had the longest progression-free survival time and was correlated to subclinical patients evaluated in the context of incidental findings or familial screening. Cluster 3 (n=48) showed the highest percentage of disease progression without cluster 1 mortality, with metabolic syndrome and cardiovascular comorbidities as the main characteristics. This cluster analysis of IPF patients suggests that diagnostic and treatment delay are the most significant factors associated with mortality, while IPF progression was more related to metabolic syndrome and cardiovascular comorbidities.

Identifiants

pubmed: 33981766
doi: 10.1183/23120541.00897-2020
pii: 00897-2020
pmc: PMC8107351
pii:
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

Copyright ©The authors 2021.

Déclaration de conflit d'intérêts

Conflict of interest: J. Bordas-Martínez reports FIS-ISCIII grant PI18/00367 (cofunded by the European Regional Development Fund (ERDF)), Spanish Society of Pneumology and Thoracic Surgery (SEPAR) grants 631/2018 and 685/2018, Emerging ILD Group of SEPAR grant 005 (Boehringer–Roche), Pneumology Foundation of Catalonia grant 2019, Spanish Sleep Society grant 2019, institutional support of the CERCA Programme/Generalitat de Catalunya, and research support BRN-Fundació Ramon Pla Armengol from ISCIII grant CM20/00093 (cofunded by European Regional Development Fund), during the conduct of the study. Conflict of interest: R. Gavaldà reports FIS-ISCIII grant PI18/00367 (cofunded by the European Regional Development Fund (ERDF)), Spanish Society of Pneumology and Thoracic Surgery (SEPAR) grants 631/2018 and 685/2018, Emerging ILD Group of SEPAR grant 005 (Boehringer–Roche), Pneumology Foundation of Catalonia grant 2019, Spanish Sleep Society grant 2019, institutional support of the CERCA Programme/Generalitat de Catalunya, and research support BRN-Fundació Ramon Pla Armengol from ISCIII grant CM20/00093 (cofunded by European Regional Development Fund), during the conduct of the study. Conflict of interest: J.G. Shull reports FIS-ISCIII grant PI18/00367 (cofunded by the European Regional Development Fund (ERDF)), Spanish Society of Pneumology and Thoracic Surgery (SEPAR) grants 631/2018 and 685/2018, Emerging ILD Group of SEPAR grant 005 (Boehringer–Roche), Pneumology Foundation of Catalonia grant 2019, Spanish Sleep Society grant 2019, institutional support of the CERCA Programme/Generalitat de Catalunya, and research support BRN-Fundació Ramon Pla Armengol from ISCIII grant CM20/00093 (cofunded by European Regional Development Fund), during the conduct of the study. Conflict of interest: V. Vicens-Zygmunt reports FIS-ISCIII grant PI18/00367 (cofunded by the European Regional Development Fund (ERDF)), Spanish Society of Pneumology and Thoracic Surgery (SEPAR) grants 631/2018 and 685/2018, Emerging ILD Group of SEPAR grant 005 (Boehringer–Roche), Pneumology Foundation of Catalonia grant 2019, Spanish Sleep Society grant 2019, institutional support of the CERCA Programme/Generalitat de Catalunya, and research support BRN-Fundació Ramon Pla Armengol from ISCIII grant CM20/00093 (cofunded by European Regional Development Fund), during the conduct of the study. Conflict of interest: L. Planas-Cerezales reports FIS-ISCIII grant PI18/00367 (cofunded by the European Regional Development Fund (ERDF)), Spanish Society of Pneumology and Thoracic Surgery (SEPAR) grants 631/2018 and 685/2018, Emerging ILD Group of SEPAR grant 005 (Boehringer–Roche), Pneumology Foundation of Catalonia grant 2019, Spanish Sleep Society grant 2019, institutional support of the CERCA Programme/Generalitat de Catalunya, and research support BRN-Fundació Ramon Pla Armengol from ISCIII grant CM20/00093 (cofunded by European Regional Development Fund), during the conduct of the study. Conflict of interest: G. Bermudo-Peloche reports FIS-ISCIII grant PI18/00367 (cofunded by the European Regional Development Fund (ERDF)), Spanish Society of Pneumology and Thoracic Surgery (SEPAR) grants 631/2018 and 685/2018, Emerging ILD Group of SEPAR grant 005 (Boehringer–Roche), Pneumology Foundation of Catalonia grant 2019, Spanish Sleep Society grant 2019, institutional support of the CERCA Programme/Generalitat de Catalunya, and research support BRN-Fundació Ramon Pla Armengol from ISCIII grant CM20/00093 (cofunded by European Regional Development Fund), during the conduct of the study. Conflict of interest: S. Santos reports FIS-ISCIII grant PI18/00367 (cofunded by the European Regional Development Fund (ERDF)), Spanish Society of Pneumology and Thoracic Surgery (SEPAR) grants 631/2018 and 685/2018, Emerging ILD Group of SEPAR grant 005 (Boehringer–Roche), Pneumology Foundation of Catalonia grant 2019, Spanish Sleep Society grant 2019, institutional support of the CERCA Programme/Generalitat de Catalunya, and research support BRN-Fundació Ramon Pla Armengol from ISCIII grant CM20/00093 (cofunded by European Regional Development Fund), during the conduct of the study. Conflict of interest: N. Salord reports FIS-ISCIII grant PI18/00367 (cofunded by the European Regional Development Fund (ERDF)), Spanish Society of Pneumology and Thoracic Surgery (SEPAR) grants 631/2018 and 685/2018, Emerging ILD Group of SEPAR grant 005 (Boehringer–Roche), Pneumology Foundation of Catalonia grant 2019, Spanish Sleep Society grant 2019, institutional support of the CERCA Programme/Generalitat de Catalunya, and research support BRN-Fundació Ramon Pla Armengol from ISCIII grant CM20/00093 (cofunded by European Regional Development Fund), during the conduct of the study. Conflict of interest: C. Monasterio reports FIS-ISCIII grant PI18/00367 (cofunded by the European Regional Development Fund (ERDF)), Spanish Society of Pneumology and Thoracic Surgery (SEPAR) grants 631/2018 and 685/2018, Emerging ILD Group of SEPAR grant 005 (Boehringer–Roche), Pneumology Foundation of Catalonia grant 2019, Spanish Sleep Society grant 2019, institutional support of the CERCA Programme/Generalitat de Catalunya, and research support BRN-Fundació Ramon Pla Armengol from ISCIII grant CM20/00093 (cofunded by European Regional Development Fund), during the conduct of the study. Conflict of interest: M. Molina-Molina reports FIS-ISCIII grant PI18/00367 (cofunded by the European Regional Development Fund (ERDF)), Spanish Society of Pneumology and Thoracic Surgery (SEPAR) grants 631/2018 and 685/2018, Emerging ILD Group of SEPAR grant 005 (Boehringer–Roche), Pneumology Foundation of Catalonia grant 2019, Spanish Sleep Society grant 2019, institutional support of the CERCA Programme/Generalitat de Catalunya, and research support BRN-Fundació Ramon Pla Armengol from ISCIII grant CM20/00093 (cofunded by European Regional Development Fund), during the conduct of the study. Conflict of interest: G. Suarez-Cuartin reports FIS-ISCIII grant PI18/00367 (cofunded by the European Regional Development Fund (ERDF)), Spanish Society of Pneumology and Thoracic Surgery (SEPAR) grants 631/2018 and 685/2018, Emerging ILD Group of SEPAR grant 005 (Boehringer–Roche), Pneumology Foundation of Catalonia grant 2019, Spanish Sleep Society grant 2019, institutional support of the CERCA Programme/Generalitat de Catalunya, and research support BRN-Fundació Ramon Pla Armengol from ISCIII grant CM20/00093 (cofunded by European Regional Development Fund), during the conduct of the study.

Références

BMJ Open Respir Res. 2018 Dec 19;5(1):e000360
pubmed: 30622718
Lung. 2017 Oct;195(5):643-651
pubmed: 28674777
Nutrition. 2019 Jun;62:115-121
pubmed: 30878815
J Heart Lung Transplant. 2020 Apr;39(4):310-320
pubmed: 32061507
Am J Respir Crit Care Med. 2016 Aug 1;194(3):265-75
pubmed: 27299520
Chest. 2009 Sep;136(3):772-778
pubmed: 19567497
Eur Respir J. 2019 Mar 7;53(3):
pubmed: 30578385
Eur Respir J. 2011 Nov;38(5):1089-97
pubmed: 21622590
Climacteric. 2016 Aug;19(4):329-36
pubmed: 27327421
Eur Respir J. 2016 Sep;48(3):833-42
pubmed: 27174889
Respiration. 2018;96(6):571-587
pubmed: 30308515
Am J Respir Crit Care Med. 2015 Jul 15;192(2):e3-19
pubmed: 26177183
J Diabetes Res. 2018 Nov 4;2018:3407306
pubmed: 30525052
PLoS One. 2016 Mar 29;11(3):e0151425
pubmed: 27023440
Med Sci (Basel). 2018 Nov 29;6(4):
pubmed: 30501130
Am J Respir Crit Care Med. 2018 Sep 15;198(6):e70-e87
pubmed: 30215551
Eur Respir Rev. 2019 Oct 1;28(153):
pubmed: 31578211
Chest. 2018 Feb;153(2):349-360
pubmed: 28964798
Respirology. 2019 Feb;24(2):146-153
pubmed: 30320420
Eur Respir J. 2005 Oct;26(4):586-93
pubmed: 16204587
Sleep Breath. 2013 Dec;17(4):1281-8
pubmed: 23563999
Medicine (Baltimore). 2018 Aug;97(34):e11775
pubmed: 30142763
Expert Rev Respir Med. 2018 Jul;12(7):537-539
pubmed: 29718749
Eur Respir J. 2012 Feb;39(2):344-51
pubmed: 21737563
Respir Res. 2019 May 24;20(1):103
pubmed: 31126287
Ann Intern Med. 2012 May 15;156(10):684-91
pubmed: 22586007
N Engl J Med. 2006 Jun 1;354(22):2340-8
pubmed: 16738270
Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304
pubmed: 11790668
Chest. 2014 Nov;146(5):1387-1394
pubmed: 25367475
Respir Med. 2018 May;138:137-143
pubmed: 29724386
Am J Respir Crit Care Med. 2011 Oct 1;184(7):842-7
pubmed: 21719755
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Eur Respir Rev. 2013 Jun 1;22(128):153-7
pubmed: 23728869
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68
pubmed: 30168753
Respir Med. 2017 Aug;129:46-52
pubmed: 28732835
Am J Gastroenterol. 2005 Jun;100(6):1243-50
pubmed: 15929752
Chest. 2009 Jul;136(1):10-15
pubmed: 19225068
J Manag Care Spec Pharm. 2017 Mar;23(3-b Suppl):S17-S24
pubmed: 28287347
Circulation. 2006 Feb 14;113(6):898-918
pubmed: 16380542

Auteurs

Jaume Bordas-Martínez (J)

Interstitial Lung Disease Unit, Respiratory Dept, Bellvitge University Hospital, IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
Sleep Unit, Respiratory Dept, Bellvitge University Hospital, IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.

Ricard Gavaldà (R)

Amalfi Analytics, Barcelona, Spain.
Computer Science Dept, Polytechnic University of Catalonia, Barcelona, Spain.

Jessica G Shull (JG)

Interstitial Lung Disease Unit, Respiratory Dept, Bellvitge University Hospital, IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.

Vanesa Vicens-Zygmunt (V)

Interstitial Lung Disease Unit, Respiratory Dept, Bellvitge University Hospital, IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.

Lurdes Planas-Cerezales (L)

Interstitial Lung Disease Unit, Respiratory Dept, Bellvitge University Hospital, IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.

Guadalupe Bermudo-Peloche (G)

Interstitial Lung Disease Unit, Respiratory Dept, Bellvitge University Hospital, IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.

Salud Santos (S)

Interstitial Lung Disease Unit, Respiratory Dept, Bellvitge University Hospital, IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
Sleep Unit, Respiratory Dept, Bellvitge University Hospital, IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.

Neus Salord (N)

Sleep Unit, Respiratory Dept, Bellvitge University Hospital, IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.

Carmen Monasterio (C)

Sleep Unit, Respiratory Dept, Bellvitge University Hospital, IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.

Maria Molina-Molina (M)

Interstitial Lung Disease Unit, Respiratory Dept, Bellvitge University Hospital, IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.

Guillermo Suarez-Cuartin (G)

Interstitial Lung Disease Unit, Respiratory Dept, Bellvitge University Hospital, IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.

Classifications MeSH